CSF beta-amyloid 1–42 – what are we measuring in Alzheimer's disease?

OBJECTIVE: To characterize biological and technical factors which influence cerebrospinal fluid (CSF) Alzheimer's disease (AD) biomarker levels, including the presence of apolipoprotein E (APOE) ε4 allele, AD diagnosis, Aβ-binding proteins, sample processing, and preanalytical handling. METHODS...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ann Clin Transl Neurol
Egile Nagusiak: Hu, William T, Watts, Kelly D, Shaw, Leslie M, Howell, Jennifer C, Trojanowski, John Q, Basra, Sundeep, Glass, Jonathan D, Lah, James J, Levey, Allan I
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BlackWell Publishing Ltd 2015
Gaiak:
Research Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4338954/
https://ncbi.nlm.nih.gov/pubmed/25750918
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.160
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak